Search for: "ELI LILLY & CO." Results 241 - 260 of 1,007
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
26 May 2015, 12:53 pm
Indianapolis, Indiana - An Indiana patent attorney for Eli Lilly and Company of Indianapolis, Indiana; Daiichi Sankyo Co., Ltd. of Tokyo, Japan; Daiichi Sankyo, Inc. of Parsippany, New Jersey; and Ube Industries, Ltd of Yamaguchi, Japan filed a federal lawsuit in the Southern District of Indiana alleging that HEC Pharm USA, Inc. of Princeton, New Jersey and HEC Pharm Co. [read post]
21 May 2015, 4:29 am by Derek T. Braslow
Last year, a federal jury in Louisiana ordered Takeda and Eli Lilly & Co., which partnered with Takeda to sell Actos in the US, to pay a combined $9 billion judgment to a plaintiff who claimed that Actos caused his bladder cancer. [read post]
1 May 2015, 12:35 pm by Dr. Shezad Malik
Actos Bladder Cancer Lawsuits Continue to Increase There are more than 4,000 federal personal injury, product liability lawsuits pending against Takeda Pharmaceuticals and Eli Lilly. [read post]
29 Apr 2015, 11:15 am
Indianapolis, Indiana - An Indiana patent lawyer for Eli Lilly and Company of Indianapolis, Indiana; Daiichi Sankyo Co., Ltd. of Tokyo, Japan; Daiichi Sankyo, Inc. of Parsippany, New Jersey; and Ube Industries, Ltd of Yamaguchi, Japan (collectively "Lilly") sued in the Southern District of Indiana alleging that Lupin Ltd. of Mumbai, India and Lupin Pharmaceuticals, Inc. of Baltimore, Maryland infringed Patent Nos. 8,569,325, titled Method of Treatment… [read post]
29 Apr 2015, 6:35 am by Dr. Shezad Malik
Actos Bladder Cancer Lawsuits Continue to Increase There are more than 4,000 federal personal injury, product liability lawsuits pending against Takeda Pharmaceuticals and Eli Lilly. [read post]
22 Apr 2015, 12:22 pm by Bloomberg
Four residents of the town of Princeton sued to revoke the school’s tax exemption, in part because it shares royalties with faculty, mostly from a patent that Eli Lilly & Co. turned into the cancer drug Alimta. [read post]
3 Apr 2015, 7:01 am by Dr. Shezad Malik
Actos Bladder Cancer Lawsuits Continue to Increase There are more than 4,000 federal personal injury, product liability lawsuits pending against Takeda Pharmaceuticals and Eli Lilly. [read post]
18 Mar 2015, 7:00 am
Feb. 26, 2015), defendant Eli Lilly & Co. moved for summary judgment in a Byetta pancreatitis case, arguing that, under the “learned intermediary” doctrine, it was entitled to summary judgment on plaintiff’s claims that Byetta’s pancreatitis warnings were inadequate.Plaintiff cross-moved for summary adjudication, arguing that manufacturer’s duty to warn ran to the plaintiff because, pursuant to 21 C.F.R. [read post]
27 Feb 2015, 6:35 am by Dr. Shezad Malik
A federal jury in Lafayette, Louisiana, last year awarded a massive $9 billion in damages against Takeda and Eli Lilly & Co. [read post]
25 Feb 2015, 8:49 am
Rosen Professor of Law; Co-director of the William S. and Christine S. [read post]
25 Feb 2015, 8:03 am
Rosen Professor of Law; Co-director of the William S. and Christine S. [read post]
13 Feb 2015, 1:13 pm by Dr. Shezad Malik
A federal jury in Lafayette, Louisiana, last year awarded a massive $9 billion in damages against Takeda and Eli Lilly & Co. [read post]
9 Feb 2015, 5:41 pm by Dr. Shezad Malik
The company’s main goal was “to protect the product,” Miller added. 4,000 Actos Bladder Cancer Lawsuits in Federal Court There are more than 4,000 product liability lawsuits filed against Takeda Pharmaceuticals and Eli Lilly, which allege that Actos diabetic medication caused patients to develop bladder cancer. [read post]
22 Jan 2015, 12:16 pm by Dr. Shezad Malik
The company’s main goal was “to protect the product,” Miller added. 4,000 Actos Bladder Cancer Lawsuits in Federal Court There are more than 4,000 product liability lawsuits filed against Takeda Pharmaceuticals and Eli Lilly, which allege that Actos diabetic medication caused patients to develop bladder cancer. [read post]
15 Jan 2015, 1:53 pm
Indianapolis, Indiana - All federal criminal charges against Guoqing Cao and Shuyu Li, who were formerly employed by Eli Lilly and Company ("Lilly"), were recently dropped by federal prosecutors, who stated that "additional information" had been received that altered "the investigative facts initially relied upon by the government" in its case against Cao and Li. [read post]